Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ruiqian Zhang
Observed names:
Ruiqian ZHANG,
Zhang, Ruiqian
Institution:
University of Hong Kong
Observed institution:
University of Hong Kong
ORCID:
0000-0002-2088-8911
Observed ORCID:
0000-0002-2088-8911
OpenAlex ID:
A5048305339
Molecular Biomarkers for the Early Detection of Ovarian Cancer
2022
·
Ruiqian Zhang
, Michelle K. Y. Siu
, et al.
·
International Journal of Molecular Sciences
·
284
PDF
SOAT1 in ovarian cancer cells regulates immune response mediated by CD8+ T cells
2025
·
Jiangnan He
, Michelle K.Y. Siu
, et al.
·
Journal of Ovarian Research
·
3
PDF
Abstract 4460: Drug repurposing in Nectin-4-positive epithelial ovarian cancer.
2026
·
Xiaoyan Zhong
, Runying Long
, et al.
·
Cancer Research
Abstract 7548: Mechanistic insights into reactive oxygen species (ROS) homeostasis in ovarian cancer chemoresistance
2026
·
Minjun HE
, Michelle K.Y. SIU
, et al.
·
Cancer Research
Abstract 7458: Examining OST4's impact on tumorigenesis and immune microenvironment in ovarian cancer
2026
·
Mengyi Gu
, Michelle K.y. Siu
, et al.
·
Cancer Research
Abstract 7752: Targeting SOAT1 to Boost NK Cell Mediated Cytotoxicity in High Grade Serous Ovarian Cancer
2026
·
Luqi Chen
, Michelle K.y. Siu
, et al.
·
Cancer Research
Supporting data for ‘Enhancing MHC‑I–Mediated Immunity by ICMT Inhibition and Personalizing Chemotherapy with Patient‑Derived Organoids in Ovarian Cancer’
2026
·
Zhang, Ruiqian
, Chan, Karen K.L.
·
Hong Kong University
Nectin-4-Directed Therapeutic Repositioning Augments Antitumor Efficacy in Epithelial Ovarian Carcinoma
2026
·
Katherine Xiaoyan Zhong
, Runying Long
, et al.
·
癌症：英文版
Show more works
View as search
Works count:
8
Citation count:
287
H-index:
2
I10-index:
1
Year
Topic
Type
